Skilled in providing strategic, operational and medical/clinical guidance for the development of new products and overall life cycle management, Dr. Huskey currently leads teams of clinical, regulatory, quality and translational genetics professionals uniquely dedicated to the development of better approaches to patient care through clinical excellence, research and education.

A dynamic, cross-functional leader with over 15 years of direct patient care, pharmaceutical and biotech experience, she is accomplished in building and leading medical and clinical affairs teams through change and growth. As Chief Clinical Officer of Millennium Health, Dr. Huskey is responsible for developing Millennium’s evidence-based clinical strategy, implementing programs to help ensure medical necessity and supporting teams through collaborative partnerships with our clinician and health plan partners. She recently co-authored a study entitled, “Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine” that was published in JAMA Network Open and picked up by several national news outlets, including U.S. News and World Report.

Before joining Millennium, Dr. Huskey held various medical affairs positions in the pharmaceutical industry; responsible for developing and managing key opinion leader relationships, clinical education, and collaborative research. As a clinician and after residency, she practiced as a clinical pharmacy specialist in both the inpatient and outpatient settings, specializing in the care of patients with substance use disorders and complex pain syndromes.

Dr. Huskey is a Certified Pain Educator (CPE) and was the 2012 recipient of the American Society of ASPEs ‘Pain Educator of the Year’ Award.

Therapeutic area specialties and expertise include:

• Emerging Illicit and Prescription Drug Use Trends
• Defining Medical Necessity
• Clinical Excellence in Laboratory Business
• Substance Use Disorders
• Pain Management
• Oncology
• Infectious Disease
• Psychiatry